#Scancell #NationalCancerInstitute #UKbiotech #DNAplasmidvaccine #melanoma #SCOPEtrial #SCIB1 #iSCIB1+ #checkpointinhibitortherapy #advancedmelanoma #immunotherapy #melanomaantigens #TRP2protein #Tcells #checkpointinhibitors #metastaticmelanomatreatment
pharmaphorum.com/news/scancel...
pharmaphorum.com/news/scancel...
Scancell points to 'strong' melanoma vaccine data
Scancell has the results it was hoping for with its melanoma immunotherapy iSCIB1+ and is accelerating plans for a pivotal trial.
pharmaphorum.com
July 31, 2025 at 8:44 AM
SCIB1/iSCIB1+ Vaccines Plus Checkpoint Inhibition Generates Immune Responses in Advanced #Melanoma
#melsm #CancerVaccine
www.onclive.com/view/scib1-i...
#melsm #CancerVaccine
www.onclive.com/view/scib1-i...
SCIB1/iSCIB1+ Vaccines Plus Checkpoint Inhibition Generates Immune Responses in Advanced Melanoma
Among patients with advanced melanoma and the target HLA type—representing 80% of the study population—treatment with iSCIB1+ yielded an ORR of 69%.
www.onclive.com
July 22, 2025 at 8:58 PM
SCIB1/iSCIB1+ Vaccines Plus Checkpoint Inhibition Generates Immune Responses in Advanced #Melanoma
#melsm #CancerVaccine
www.onclive.com/view/scib1-i...
#melsm #CancerVaccine
www.onclive.com/view/scib1-i...